Back
Crinetics Pharmaceuticals Stock Price Chart
Sponsored
CRNX
Sponsored
The 7 new tech giants dominating today's markets
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Sell
28
CRNX
Crinetics Pharmaceuticals
Last Price:
$53.63
Seasonality Move:
-9.59%
7 Day Trial
ALL ACCESS PASS
$
7
How to Turn the AI Energy Crisis into BIG Profits
And investors who move now into one technology could make a whole lot of money.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight buying pressure.
Crinetics Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.72 | Sell |
20-day SMA: | 56.15 | Sell |
50-day SMA: | 56.8 | Sell |
200-day SMA: | 50.48 | Buy |
8-day EMA: | 54.34 | Sell |
20-day EMA: | 55.59 | Sell |
50-day EMA: | 55.73 | Sell |
200-day EMA: | 49.77 | Buy |
Crinetics Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.88 | Sell |
Relative Strength Index (14 RSI): | 43.22 | Sell |
Chaikin Money Flow: | 720885 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.12 - 57.86) | Sell |
Bollinger Bands (100): | (51.17 - 57.47) | Sell |
Crinetics Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Crinetics Pharmaceuticals Stock
Is Crinetics Pharmaceuticals Stock a Buy?
-
Crinetics Pharmaceuticals share price is 53.50 while CRNX 8-day simple moving average is 54.72, which is a Sell signal.
-
The stock price of CRNX is 53.50 while Crinetics Pharmaceuticals 20-day SMA is 56.15, which makes it a Sell.
-
Crinetics Pharmaceuticals 50-day simple moving average is 56.80 while CRNX share price is 53.50, making it a Sell technically.
-
CRNX stock price is 53.50 and Crinetics Pharmaceuticals 200-day simple moving average is 50.48, creating a Buy signal.
CRNX Technical Analysis vs Fundamental Analysis
Sell
28
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy or a Sell?
-
Crinetics Pharmaceuticals stock is rated a SellThe current Crinetics Pharmaceuticals [CRNX] share price is $53.50. The Score for CRNX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Crinetics Pharmaceuticals Stock Info
Market Cap:
5B
Price in USD:
53.50
Share Volume:
1.8M
Crinetics Pharmaceuticals 52-Week Range
52-Week High:
62.53
52-Week Low:
33.67
Sell
28
Crinetics Pharmaceuticals (CRNX)
is a Sell
Crinetics Pharmaceuticals Share Price Forecast
-
What is the Crinetics Pharmaceuticals stock price today?The Crinetics Pharmaceuticals stock price is 53.50 USD today.
-
Will CRNX stock go up or go down?Crinetics Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Crinetics Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Crinetics Pharmaceuticals is overvalued.
Is Crinetics Pharmaceuticals Stock a Buy?
-
Crinetics Pharmaceuticals share price is 53.50 while CRNX 8-day exponential moving average is 54.34, which is a Sell signal.
-
The stock price of CRNX is 53.50 while Crinetics Pharmaceuticals 20-day EMA is 55.59, which makes it a Sell.
-
Crinetics Pharmaceuticals 50-day exponential moving average is 55.73 while CRNX share price is 53.50, making it a Sell technically.
-
CRNX stock price is 53.50 and Crinetics Pharmaceuticals 200-day simple moving average is 49.77, creating a Buy signal.
Fundamental Analysis of Crinetics Pharmaceuticals
Is Crinetics Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.18 per share.
Technical Analysis of Crinetics Pharmaceuticals
Should I short Crinetics Pharmaceuticals stock?
-
CRNX Moving Average Covergence Divergence (MACD) indicator is -0.88, suggesting Crinetics Pharmaceuticals is a Sell
-
Crinetics Pharmaceuticals Relative Strength Index (RSI) is 43.22, which suggest Crinetics Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Crinetics Pharmaceuticals is (54.12 - 57.86), which suggest Crinetics Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Crinetics Pharmaceuticals is (51.17 - 57.47), which suggest Crinetics Pharmaceuticals is a Sell
* Crinetics Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.